SE460334B - Farmaceutiska preparat, innefattande humant insulin och human c-peptid - Google Patents

Farmaceutiska preparat, innefattande humant insulin och human c-peptid

Info

Publication number
SE460334B
SE460334B SE8204873A SE8204873A SE460334B SE 460334 B SE460334 B SE 460334B SE 8204873 A SE8204873 A SE 8204873A SE 8204873 A SE8204873 A SE 8204873A SE 460334 B SE460334 B SE 460334B
Authority
SE
Sweden
Prior art keywords
human
insulin
peptide
units
composition
Prior art date
Application number
SE8204873A
Other languages
English (en)
Swedish (sv)
Other versions
SE8204873L (sv
SE8204873D0 (sv
Inventor
R E Chance
B H Frank
J A Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE8204873D0 publication Critical patent/SE8204873D0/xx
Publication of SE8204873L publication Critical patent/SE8204873L/
Publication of SE460334B publication Critical patent/SE460334B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8204873A 1981-08-27 1982-08-25 Farmaceutiska preparat, innefattande humant insulin och human c-peptid SE460334B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (3)

Publication Number Publication Date
SE8204873D0 SE8204873D0 (sv) 1982-08-25
SE8204873L SE8204873L (sv) 1983-02-28
SE460334B true SE460334B (sv) 1989-10-02

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204873A SE460334B (sv) 1981-08-27 1982-08-25 Farmaceutiska preparat, innefattande humant insulin och human c-peptid

Country Status (20)

Country Link
JP (1) JPS5846024A (it)
AU (1) AU551879B2 (it)
BE (1) BE894185A (it)
CA (1) CA1176158A (it)
CH (1) CH650679A5 (it)
DE (1) DE3232034A1 (it)
DZ (1) DZ452A1 (it)
FR (1) FR2513126B1 (it)
GB (1) GB2104382B (it)
IE (1) IE54119B1 (it)
IL (1) IL66611A0 (it)
IT (1) IT1153182B (it)
LU (1) LU84359A1 (it)
MW (1) MW3882A1 (it)
NL (1) NL192192C (it)
NZ (1) NZ201682A (it)
PH (1) PH19361A (it)
SE (1) SE460334B (it)
ZA (1) ZA826159B (it)
ZW (1) ZW17482A1 (it)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964558B2 (en) 2003-10-13 2011-06-21 La Jolla Therapeutic applications for C-peptide
EP2898900A1 (en) 2008-09-19 2015-07-29 Nektar Therapeutics Polymer conjugates of ziconotide

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
WO1988002633A1 (en) * 1986-10-20 1988-04-21 Novo Industri A/S Protamine zinc insulin preparations
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
CA1339416C (en) * 1987-02-25 1997-09-02 Liselotte Langkjaer Insulin derivatives
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
WO2006053906A1 (en) * 2004-11-22 2006-05-26 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
KR20130115086A (ko) * 2010-05-17 2013-10-21 세빅스 인코포레이티드 페길화된 c-펩티드
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964558B2 (en) 2003-10-13 2011-06-21 La Jolla Therapeutic applications for C-peptide
EP2898900A1 (en) 2008-09-19 2015-07-29 Nektar Therapeutics Polymer conjugates of ziconotide

Also Published As

Publication number Publication date
IT1153182B (it) 1987-01-14
BE894185A (fr) 1983-02-24
IE54119B1 (en) 1989-06-21
DZ452A1 (fr) 2004-09-13
FR2513126A1 (fr) 1983-03-25
IT8223017A0 (it) 1982-08-27
ZA826159B (en) 1984-04-25
NL192192B (nl) 1996-11-01
ZW17482A1 (en) 1982-11-17
PH19361A (en) 1986-04-02
NL8203315A (nl) 1983-03-16
GB2104382A (en) 1983-03-09
DE3232034C2 (it) 1991-04-11
NL192192C (nl) 1997-03-04
AU8759482A (en) 1983-03-03
NZ201682A (en) 1985-08-16
MW3882A1 (en) 1984-07-11
DE3232034A1 (de) 1983-03-10
SE8204873L (sv) 1983-02-28
LU84359A1 (fr) 1983-02-28
FR2513126B1 (fr) 1986-04-18
SE8204873D0 (sv) 1982-08-25
AU551879B2 (en) 1986-05-15
IL66611A0 (en) 1982-12-31
JPS5846024A (ja) 1983-03-17
GB2104382B (en) 1984-12-19
CA1176158A (en) 1984-10-16
IE822064L (en) 1983-02-27
CH650679A5 (de) 1985-08-15

Similar Documents

Publication Publication Date Title
US4608364A (en) Pharmaceutical agent for the treatment of diabetes mellitus
US5922675A (en) Acylated Insulin Analogs
KR100546225B1 (ko) 신속한 작용개시를 나타내는 인슐린 유도체
DK172209B1 (da) Lægemidler indeholdende basisk modificerede insulinderivater
SE460334B (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
JP2837956B2 (ja) Ａｓｐ▲上Ｂ２８▼インスリン結晶
US5008241A (en) Novel insulin peptides
EP0216832B1 (en) Novel insulin derivatives and pharmaceutical preparations containing these derivatives
CN101389650A (zh) 包含酰化胰岛素和锌的组合物以及制备所述组合物的方法
PT98124A (pt) Processo para a preparacao de novos analogos de insulina com accao prolongada e de composicoes farmaceuticas que os contem
HU203371B (en) Process for producing new insulin derivatives and injection solutions comprising same
Markussen et al. Soluble, prolonged-acting insulin derivatives. I. Degree of protraction and crystallizability of insulins substituted in the termini of the B-chain
Dimaline et al. Potent stimulation of the avian exocrine pancreas by porcine and chicken vasoactive intestinal peptide.
JP3131215B2 (ja) 新規インスリン誘導体
CA1176161A (en) Pharmaceutical formulations comprising human insulin and human proinsulin
HU203840B (en) Process for producing mixed cristals suspension and mixed cristals containing native insuline and basically modificated insuline and injectable composition contining them
HU206375B (en) Process for producing biologically active, stable somatotropins and pharmaceutical compositions comprising same as active ingredient
KR20050036865A (ko) 당뇨병 치료를 위한 조성물 및 방법
Holst et al. On the effects of human galanin in man
US20010041786A1 (en) Stabilized acylated insulin formulations
PL198190B1 (pl) Analogi insuliny, sposób ich wytwarzania, prekursory analogów insuliny, sekwencje DNA kodujące te prekursory, wektory ekspresyjne, komórka gospodarza, środek farmaceutyczny, roztwór o aktywności insulinowej, zastosowanie analogów insuliny, kompleksy insuliny z cynkiem i ich zastosowanie
Skyler Insulin pharmacology
Nishii et al. Isolation and characterization of [Pro2] somatostatin-14 and melanotropins from Russian sturgeon, Acipenser gueldenstaedti Brandt
AU669636B2 (en) Amylin antagonists and agonists
CA1176159A (en) Pharmaceutical formulations comprising human insulin, human c-peptide, and human proinsulin

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8204873-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8204873-7

Format of ref document f/p: F